Community Academic Profiles–

Po Wang

Back to Profile

Publication Details

  • Open adjunctive ziprasidone associated with weight loss in obese and overweight bipolar disorder patients.

    Wang PW, Hill SJ, Childers ME, Chandler RA, Rasgon NL, Ketter TA. J Psychiatr Res. 2011; 45 (8): 1128-32

    To assess effectiveness and tolerability of open adjunctive ziprasidone for weight loss in obese/overweight patients with bipolar disorders (BD) in diverse mood states, taking weight gain-implicated psychotropic medications.

    PubMedID: 21371718

Stanford Medicine Resources:

Footer Links: